Ieq Capital LLC Raises Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Ieq Capital LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 3.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 54,893 shares of the company’s stock after buying an additional 1,587 shares during the period. Ieq Capital LLC’s holdings in Doximity were worth $2,931,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in DOCS. FMR LLC raised its position in Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares during the last quarter. Lord Abbett & CO. LLC bought a new position in shares of Doximity during the third quarter valued at approximately $29,453,000. Los Angeles Capital Management LLC lifted its stake in Doximity by 6,242.6% in the third quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock worth $28,359,000 after acquiring an additional 640,612 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Doximity in the third quarter valued at $24,691,000. Finally, Geode Capital Management LLC boosted its holdings in Doximity by 19.8% in the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after acquiring an additional 472,565 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of Doximity stock opened at $72.25 on Friday. The stock has a market cap of $13.49 billion, a price-to-earnings ratio of 72.25, a PEG ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The firm’s 50-day moving average is $60.19 and its 200 day moving average is $49.21.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 37.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on DOCS shares. Stephens assumed coverage on shares of Doximity in a research report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 target price for the company. Barclays raised their price objective on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $33.00 to $53.00 in a research report on Thursday, November 14th. Finally, Canaccord Genuity Group lifted their price target on Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity has an average rating of “Moderate Buy” and a consensus price target of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.